Does prostate-specific antigen nadir predict longer-term outcomes of prostate cancer after neoadjuvant and adjuvant androgen deprivation therapy in conjunction with brachytherapy?-Reference-Cited by-同舟云学术

Does prostate-specific antigen nadir predict longer-term outcomes of prostate cancer after neoadjuvant and adjuvant androgen deprivation therapy in conjunction with brachytherapy?

Published:2015-05 Issue:3 Volume:14 Page:322-328
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Morris Lucinda May,Izard Michael Anthony,Wan Wai-Yin

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference28 articles.

1. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG ASTRO Phoenix Consensus Conference;Roach;Int J Radiat Oncol Biol Phys,2006

2. Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?;Denham;Cancer,2009

3. A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: Analysis of data from the TROG 96.01 randomized trial;Lamb;Int J Radiat Oncol Biol Phys,2011

4. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial;Pollack;Int J Radiat Oncol Biol Phys,2002

5. Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death;Alcantara;Cancer,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer;Strahlentherapie und Onkologie;2021-04-28

2. Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer;Brachytherapy;2017-09

3. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease;European Urology;2017-03

4. Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure;Radiotherapy and Oncology;2016-06

5. Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer;Journal of Contemporary Brachytherapy;2016